Edition:
United States

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

81.58USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$81.58
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
86,255
52-wk High
$95.64
52-wk Low
$27.53

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.02 September 20 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 2 3 3
(3) HOLD 3 2 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.75 2.50 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 1 34.44 34.44 34.44 --
Quarter Ending Mar-18 4 30.39 33.46 25.60 --
Year Ending Sep-18 4 140.63 149.62 135.60 89.00
Year Ending Sep-19 4 150.84 168.00 119.39 --
Earnings (per share)
Quarter Ending Dec-18 1 0.02 0.02 0.02 --
Quarter Ending Mar-18 4 0.09 0.21 -0.05 --
Year Ending Sep-18 4 0.94 1.36 0.68 -0.24
Year Ending Sep-19 4 -0.09 0.88 -1.16 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 31.15 38.11 6.96 22.33
Quarter Ending Sep-17 73.80 75.93 2.13 2.88
Quarter Ending Jun-17 8.07 7.51 0.56 6.98
Quarter Ending Mar-17 9.19 8.96 0.23 2.53
Quarter Ending Dec-16 11.94 10.42 1.52 12.72

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 34.44 34.44 -- -- --
Quarter Ending Mar-18 30.39 30.39 17.80 17.08 --
Year Ending Sep-18 140.63 140.63 85.94 85.18 89.00
Year Ending Sep-19 150.84 150.84 103.79 102.20 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 -- --
Quarter Ending Mar-18 0 0 3 0
Year Ending Sep-18 0 0 4 0
Year Ending Sep-19 0 0 2 0
Earnings